Walk-through survey report at oral contraceptive manufacturing operations at Ortho Pharmaceutical Corporation, Raritan New Jersey.
Authors
NIOSH
Source
Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, IWS 85-14, 1979 Jun; :1-13
Link
NIOSHTIC No.
00111345
Abstract
Worker exposure to estrogens were studied at the Ortho Pharmaceutical Corporation (SIC-2834) in Raritan, New Jersey, on June 20, 1978. The company was under consideration for inclusion in a NIOSH study of the health effects of occupational estrogen exposure. Approximately 40 of the employees at the facility were assigned to the estrogen processing area. The company maintained a safety and industrial hygiene program, and a medical program. Personnel records provided demographic data, department assignments, and absence reports. Symptoms of estrogen exposure have not been reported among processing technicians since 1976. Work categories with the greatest potential for estrogen exposure were processing technicians, packaging area operators, quality assurance inspectors or laboratory technicians, and maintenance workers. The authors conclude that this workforce should not be included in the epidemiological study since all personnel records are destroyed 7 years after employee termination. In addition, only a relatively small number of employees are exposed to the estrogens, women are excluded from the production area, and the exposure period is relatively short.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.